Webcasts & Presentations

Neurocrine’s management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com


Neurocrine Biosciences Reports Year-End 2016 Results and Provides Investor Update for 2017
February 14, 2017  5:00pmET (2:00pm PT)
Earnings Webcastreplay is available until 3/14/17  11:59pmET

Neurocrine and BIAL Announce Exclusive North American Licensing Agreement for Opicapone
February 9, 2017 at 4:30pm ET (1:30pm PT)
Licensing Webcast replay is available until 3/9/17  11:59pmET

Neurocrine Announces Completion of Phase II Clinical Study of VMAT2 Inhibitor INGREZZA TM (valbenazine) in Adults with Tourette Syndrome

January 17, 2017  4:30pm ET (1:30pm PT)
Top-Line Results
replay is available until 2/17/17  11:59pmET


CORPORATE PRESENTATION (PDF) This presentation provides an overview of our company pipeline, program progress, and financial highlights.